The Hospital District of Helsinki and Uusimaa
Helsinki, Finland
Location status: Recruiting
NCT Number: NCT03323112
This is an investigator-initiated 10 year long open cohort observational study, aiming to increase the understanding of the humoral and cellular immunological mechanisms of vaccination against influenza, including effects of repeated vaccination, the duration of protection, immunity against circulating viruses, as well as factors affecting the immunological responses and immunity against other vaccine preventable infectious diseases among health care personnel.
Interested in participating?
Request Info18 year–64 year
All sexes
Observational
Helsinki, Finland
Location status: Recruiting
Influenza vaccination is given according to the normal routine of Hospital District of Helsinki and Uusimaa (HUS) occupational health care. Blood samples will be collected before vaccination, 5 weeks after vaccination and 6 months after vaccination. Both the same participants and also new participants will be recruited each year. The analysis will be mainly descriptive.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vaccine for prevention of influenza. Vaccines change by influenza season.
Time frame: 10 years
The presence and titer of antibodies against circulating influenza virus strains and vaccine strains of the current season from pre- and post-vaccination serum samples
Time frame: 10 years
To assess the presence and titer of antibodies to circulating influenza strains and vaccine virus strains of previous seasons from pre- and post-vaccination serum samples
Time frame: 10 years
The cellular immune responses to circulating influenza viruses and vaccine strains of the current and previous seasons from pre- and post-vaccination peripheral blood mononuclear cells (PBMCs) and cell culture supernatants
Time frame: 10 years
The effect of the number of previous influenza vaccinations on the quality and quantity of Humoral and cellular immunity to circulating influenza strains and vaccine strains of the current and previous seasons
Time frame: 10 years
Exploration of biological or chemical factors that are/will be known or suspected to affect the humoral and/or cellular immune responses to influenza viruses or vaccination
Time frame: 10 years
Assessment of humoral and cellular immunity to microbes other than influenza virus causing vaccine preventable diseases
Time frame: 10 years
developing laboratory methodologies to assess immunity to influenza and other microbes causing vaccine preventable diseases
Contact information is provided by the study sponsor or research team.
Hanna Nohynek, MD, PhD
CONTACT
Merit Melin, PhD
CONTACT
Finnish Institute for Health and Welfare
Other Gov
Immune Responses to Influenza Vaccinations and Viruses Among Health Care Personnel
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07215858
Human, Infections
Bethesda, Maryland, United States
View Trial DetailsNCT01386424
Arbovirus Infections, Flaviviridae Infections
Bethesda, Maryland, United States
View Trial DetailsNCT07485855
Hematologic Diseases, Hematologic Neoplasms
Seoul, South Korea
View Trial DetailsNCT07110532
Infections, Influenza
Baltimore, Maryland, United States
View Trial Details